CD274 and glioblastoma: A Kruskal–Wallis test showed a significant (p < 0.05) change in the expression levels of PD-L1 in different subtypes of GBM, with the mesenchymal showing an elevated expression level of PD-L1 compared to other groups (Figure 6A).